Chris Pickard has over 30 years of experience in airport and infrastructure planning. He's also passionate about sustainability and the need for aviation to decarbonize. Chris holds master’s degrees in sustainability and airport planning, and a bachelor’s degree in civil engineering.
BJ Lechler is a Senior Hydrogeologist in Jacobs’ Irvine, California office with 20+ years of experience in groundwater consulting for municipal, federal and industrial clients.
As Jacobs Global Principal for Emerging Contaminants and Research, Scott Grieco is part of our global team of technical leaders delivering innovative solutions for the treatment and removal of PFAS and other emerging contaminants from water and the environment.
Scott Parker, PE, leads Jacobs’ New Jersey transportation planning group. He was instrumental in applying for and securing Maritime Administration (MARAD) funding alongside the New Jersey Department of Transportation and Federal Business Centers. Inc. for preliminary design and environmental permitting
Ryan White, AICP leads Jacobs’ New York transportation planning group. While working at the NYC Economic Development Corporation (EDC), he helped create the North Atlantic Marine Highway Alliance (NAMHA). Ryan also worked with the Port Authority of New York &
Alison has 12 years of experience in the industry and is a Chartered Water and Environmental Manager, Chartered Environmentalist and Chartered Scientist. She has been a technical project manager on numerous multi-disciplinary projects, involving integrated catchment management and nature-based solutions.
David Sandercock leads Jacobs’ U.K. Contracts and Procurement Advisory team. With over 30 years of experience in the industry, David brings a deep understanding of major infrastructure delivery across multiple sectors. This includes various contracting and procurement models, from traditional
Todd Rumsey has over 20 years of multi-discipline design experience in the biotech and pharmaceutical industries. His design experiences span across the process, process simulation, automation and validation disciplines; with a particular niche in bulk biologics, gene therapy and cell therapy manufacturing applications. His recent focus has been the design of multi-modal facilities incorporating traditional biologics, ATMP and RNA products.
